BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17691073)

  • 1. Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.
    Monti MC; Casapullo A; Cavasotto CN; Napolitano A; Riccio R
    Chembiochem; 2007 Sep; 8(13):1585-91. PubMed ID: 17691073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inactivation of phospholipase A2 by scalaradial: a biomimetic study by electrospray mass spectrometry.
    Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
    Rapid Commun Mass Spectrom; 2005; 19(3):303-8. PubMed ID: 15645482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inactivation mechanism of human group IIA phospholipase A(2) by Scalaradial.
    Margarucci L; Monti MC; Chini MG; Tosco A; Riccio R; Bifulco G; Casapullo A
    Chembiochem; 2012 Oct; 13(15):2259-64. PubMed ID: 23008213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step inactivation of bee venom phospholipase A2 by scalaradial.
    de Carvalho MS; Jacobs RS
    Biochem Pharmacol; 1991 Sep; 42(8):1621-6. PubMed ID: 1930288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of phospholipase A2 inhibition by petrosaspongiolide M.
    Dal Piaz F; Casapullo A; Randazzo A; Riccio R; Pucci P; Marino G; Gomez-Paloma L
    Chembiochem; 2002 Jul; 3(7):664-71. PubMed ID: 12325001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
    J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2.
    Xie Y; Liu L; Huang X; Guo Y; Lou L
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1210-7. PubMed ID: 15923342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of bee venom phospholipase A2 inactivation by bolinaquinone.
    Monti MC; Casapullo A; Santomauro C; D'Auria MV; Riccio R; Gomez-Paloma L
    Chembiochem; 2006 Jun; 7(6):971-80. PubMed ID: 16671124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further insights on the structural aspects of PLA(2) inhibition by gamma-hydroxybutenolide-containing natural products: a comparative study on petrosaspongiolides M-R.
    Monti MC; Casapullo A; Riccio R; Gomez-Paloma L
    Bioorg Med Chem; 2004 Mar; 12(6):1467-74. PubMed ID: 15018920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic regulation of extracellular signal-regulated kinases by scalaradial, a secretory phospholipase A(2) inhibitor.
    Xie Y; Yu Z; Liu L; Guo Y; Lou L
    Cancer Biol Ther; 2006 Aug; 5(8):988-92. PubMed ID: 16760675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production.
    Glaser KB; Lock YW
    Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2.
    Glaser KB; Vedvick TS; Jacobs RS
    Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
    Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
    Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
    Randazzo A; Debitus C; Minale L; García Pastor P; Alcaraz MJ; Payá M; Gomez-Paloma L
    J Nat Prod; 1998 May; 61(5):571-5. PubMed ID: 9599251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manoalide.
    Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; Payá M; Alcaraz MJ
    Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation.
    Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ
    Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function.
    Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM
    Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.
    Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2.
    Jacobson PB; Schrier DJ
    J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of petrosaspongiolide R on the surface topology of bee venom PLA(2): a limited proteolysis and mass spectrometry analysis.
    Monti MC; Riccio R; Casapullo A
    Bioorg Chem; 2009 Feb; 37(1):6-10. PubMed ID: 18945473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.